Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 21

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 21
---
 992 Keystone Commitment Shares. We previously filed a registration statement on Form S-1 (File No. 333-278603), which was declared effective by the SEC on May 1, 2024, and remains in effect, with respect to up to: (i) 12,500 Keystone Purchase Shares and (ii) 310 Keystone Commitment Shares. As of the date of this prospectus, we have issued and sold 11,689 shares of Common Stock for aggregate proceeds of approximately $4,410,616 under the Keystone Equity Financing and no February 2024 Keystone Purchase Shares remain available for issuance under the February 2024 Keystone Purchase Agreement. In November 2024, in order to enable us to issue and sell additional shares in excess of the Initial Limit and up to $25,000,000, we entered into the November 2024 Keystone Purchase Agreement with Keystone, pursuant to which we may issue and sell up to $20,589,384 of shares of Common Stock (the “November 2024 Keystone Purchase Shares”). We previously filed a registration statement on Form S-1 (File No. 333-283492), which was declared effective on December 5, 2024, as amended by the post-effective amendment No. 1 thereto, which post-effective amendment No. 1 was declared effective by the SEC on May 29, 2025, and remains in effect, with respect to up to: (i) 104,318 Keystone Purchase Shares and (ii) 682 Keystone Commitment Shares. As of the date of this prospectus, we have issued and sold 100,581 November 2024 Keystone Purchase Shares for aggregate proceeds of approximately $3,105,538 and no November 2024 Keystone Purchase Shares remain available for issuance under the November 2024 Keystone Purchase Agreement. In July 2025, in order to enable us to issue and sell additional shares in excess of the Initial Limit and up to $25,000,000, we entered into the July 2025 Keystone Purchase Agreement with Keystone, pursuant to which we may issue and sell up to $17,490,897 of shares of Common Stock, minus $7,076 in additional proceeds of sales pursuant to the prior registration statements described herein above (the “July 2025 Keystone Purchase Shares”). We previously filed a registration statement on Form S-1 (File No. 333-288816), which was declared effective by the SEC on July 29, 202